Alzamend Neuro (ALZN) Market Capitalization (2021 - 2026)

Alzamend Neuro has disclosed Market Capitalization across 6 years of filings, most recently posting $3.8 million for Q2 2026.

• In Q2 2026, Market Capitalization rose 42.07% year-over-year to $3.8 million; the TTM figure through Apr 2026 stood at $3.8 million (up 42.07% YoY), while the FY2026 annual figure was $3.8 million, up 42.07% from the prior year.
• Market Capitalization came in at $3.8 million for Q2 2026 at Alzamend Neuro, down from $8.2 million in the prior quarter.
• In the past five years, Market Capitalization ranged from a high of $137.9 million in Q1 2022 to a low of $2.7 million in Q2 2025.
• Average Market Capitalization over 5 years is $36.7 million, with a median of $8.9 million recorded in 2025.
• Year-over-year, Market Capitalization tumbled 93.0% in 2024 and jumped 73.46% in 2025.
• Over 5 years, Market Capitalization stood at $111.7 million in 2022, then slumped by 88.84% to $12.5 million in 2023, then tumbled by 55.53% to $5.5 million in 2024, then jumped by 73.46% to $9.6 million in 2025, then slumped by 60.45% to $3.8 million in 2026.
• Per Business Quant data, the three most recent Market Capitalization figures were $3.8 million in Q2 2026, $8.2 million in Q1 2026, and $9.6 million in Q4 2025.